Regulatory Status FDA Approval: Glutathione is not approved by the FDA (U $ Peptide in the Light of the New Gene Data." The American Journal of Clinical Nutrition
However, this trial did not specifically assess muscle mass as a primary or secondary endpoint, and the extent of any changes in lean mass versus fat mass requires further investigation with dedicated body composition measures
L.RossingP.ScottD.ShamkhalovaM
In March 2024, the Food and Drug Administration removed the specific BMI requirements from semaglutide's label, partly to correct for the limitations of BMI as a measurement tool, a metric that researchers had long argued was developed on European populations and doesn't translate well across different bodies
Retatrutide is generating more legitimate scientific interest than almost anything else in the weight loss and metabolic health space right now
Generic market entry On 21 March, Dr Reddys, Sun Pharma, Zydus Lifesciences, Glenmark, Alkem, and Natco launched generic semaglutide formulations